tiprankstipranks
Viridian Therapeutics (VRDN)
NASDAQ:VRDN
US Market
VRDN
Viridian Therapeutics
RESEARCH TOOLSreports

Viridian Therapeutics (VRDN) Income Statement

1,502 Followers

Viridian Therapeutics Income Statement

Last quarter (Q4 2025), Viridian Therapeutics's total revenue was $132.00K, an increase of 83.33% from the same quarter last year. In Q4, Viridian Therapeutics's net income was $-120.36M. See Viridian Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 70.85M$ 302.00K$ 314.00K$ 1.77M$ 2.96M
Gross Profit
$ 69.69M$ 302.00K$ 314.00K$ 1.77M$ 2.96M
Operating Expenses
$ 434.24M$ 299.34M$ 254.76M$ 136.08M$ 82.69M
Depreciation and Amortization
$ 1.16M$ 1.24M$ 522.00K$ 255.00K$ 120.00K
EBITDA
$ -337.65M$ -265.66M$ -235.37M$ -129.13M$ -79.29M
Operating Income
$ -363.39M$ -299.04M$ -254.45M$ -134.30M$ -79.73M
Other Income/Expenses
$ 20.79M$ 29.09M$ 16.72M$ 4.43M$ 315.00K
Pretax Income
$ -342.60M$ -269.95M$ -237.73M$ -129.87M$ -79.41M
Net Income
$ -342.60M$ -269.95M$ -237.73M$ -129.87M$ -79.41M
Per Share Metrics
Basic EPS
$ -3.32$ -3.98$ -5.31$ -3.91$ -6.66
Diluted EPS
$ -3.32$ -3.98$ -5.31$ -3.91$ -6.66
Weighted Average Shares Outstanding
 84.80M 67.89M 44.76M 32.09M 11.92M
Weighted Average Shares Outstanding (Diluted)
 84.80M 67.89M 44.76M 32.09M 11.92M
Currency in USD

Viridian Therapeutics Earnings and Revenue History